NCT00033384View on ClinicalTrials.gov

CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Breast CancerColorectal CancerLung CancerPancreatic Cancer
Interventions
DRUG

CI-1040

Trial Locations (1)

35294-3300

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT00033384 - CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter